By Michael Dabaie

GE Healthcare said it received U.S. Food and Drug Administration 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems.

The healthcare business of General Electric Co. said this includes new features based on artificial intelligence that enable clinicians to acquire faster, more repeatable exams consistently.

"With the Vivid Ultra Edition, we offer AI capabilities that help address healthcare providers' two key challenges in echo exams--how time consuming the exam is and the degree of variability that exists in the quantitative results," said Dagfinn Saetre, general manager of cardiovascular ultrasound at GE Healthcare.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

October 12, 2020 08:26 ET (12:26 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
GE Aerospace (NYSE:GE)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more GE Aerospace Charts.
GE Aerospace (NYSE:GE)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more GE Aerospace Charts.